title: Prevalence, characteristics and prognostic significance of anemia in daily practice.
abstract: BACKGROUND
  The prevalence of anemia has been studied in well-defined populations, but no large study is available for less restricted populations with various disorders.
  
  
  METHODS
  Two-phase nationwide study: (i) a cross-sectional study including 1351 patients aimed to define the prevalence and characteristics of anemic patients seen in France, and (ii) a prospective longitudinal study of 398 anemic patients aimed to define factors associated with survival.
  
  
  RESULTS
  Anemia was present in 874 (65%) patients according to WHO criteria, and 573 (42%) patients had hemoglobin levels <110 g/l. Characteristics independently associated with anemia were the presence of cancer, hematological disorder, renal failure and inflammatory syndrome. Baseline factors negatively associated with the 3-month survival were cancer, older age and a lower target hemoglobin level defined at baseline. Negative predictive factors at Month 3 of the 6-month survival were older age and the absence of correction of anemia according to the target hemoglobin level defined at baseline.
  
  
  CONCLUSIONS
  Anemia is frequent and is associated with cancer, hematological disorders, renal failure and inflammatory syndrome. At baseline, prognostic factors of 3-month survival include cancer, older age and lower target hemoglobin level, whereas reaching the target hemoglobin level at Month 3 has a favorable prognostic impact on 6-month survival.
authors: Department of Internal Medicine, APHP Groupe Hospitalier Pitié-Salpé trière, Université Pierre et Marie Curie, Paris 6, Paris, France.
authors: B
authors: B
authors: Terrier
authors: M
authors: M
authors: Resche-Rigon
authors: E
authors: E
authors: Andres
authors: F
authors: F
authors: Bonnet
authors: E
authors: E
authors: Hachulla
authors: I
authors: I
authors: Marie
authors: E
authors: E
authors: Rosenthal
authors: P
authors: P
authors: Cacoub
mesh_terms: D000368:Aged; D000740:Anemia / Q000097:blood / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D004812:Epidemiologic Methods; D005260:Female; D005602:France / Q000453:epidemiology; D006402:Hematologic Diseases / Q000150:complications / Q000453:epidemiology; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000453:epidemiology; D011379:Prognosis; D051437:Renal Insufficiency / Q000150:complications / Q000453:epidemiology; D017678:Sex Distribution; D018746:Systemic Inflammatory Response Syndrome / Q000150:complications / Q000453:epidemiology
chemical_list: D006454:Hemoglobins